tRNA-derived fragments: Key determinants of cancer metastasis with emerging therapeutic and diagnostic potentials
Related Experiment Video
Updated: Jul 2, 2025

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
Mohammad Salehi1, Mohammad Javad Kamali2, Aliakbar Rajabzadeh3
1Department of Medical Genetics, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran; Student Research Committee, Golestan University of Medical Sciences, Gorgan, Iran.
Abstract:
Metastasis is a significant clinical challenge responsible for cancer mortality and non-response to treatment. However, the molecular mechanisms driving metastasis remain unclear, limiting the development of efficient diagnostic and therapeutic approaches. Recent breakthroughs in cancer biology have discovered a group of small non-coding RNAs called tRNA-derived fragments (tRFs), which play a critical role in the metastatic behavior of various tumors. tRFs are produced from cleavage modifications of tRNAs and have different functional classes based on the pattern of these modifications. They perform post-transcriptional regulation through microRNA-like functions, displacing RNA-binding proteins, and play a role in translational regulation by inducing ribosome synthesis, translation initiation, and epigenetic regulation. Tumor cells manipulate tRFs to develop and survive the tumor mass, primarily by inducing metastasis. Multiple studies have demonstrated the potential of tRFs as therapeutic, diagnostic, and prognostic targets for tumor metastasis. This review discusses the production and function of tRFs in cells, their aberrant molecular contributions to the metastatic environment, and their potential as promising targets for anti-metastasis treatment strategies.
Insights
Small non-coding RNAs called tRNA-derived fragments (tRFs) are key drivers of cancer metastasis. Targeting these tRFs offers promising new strategies for anti-metastasis therapies and diagnostics.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Biology
Background:
- Metastasis is a major cause of cancer mortality and treatment failure.
- The molecular mechanisms underlying metastasis are not fully understood.
- tRNA-derived fragments (tRFs) are emerging as critical regulators of tumor progression.
Purpose of the Study:
- To review the biogenesis and functions of tRFs.
- To elucidate the role of tRFs in promoting cancer metastasis.
- To explore the potential of tRFs as therapeutic and diagnostic targets for metastasis.
Main Methods:
- Literature review of studies on tRFs and cancer metastasis.
- Analysis of tRF production from tRNA modifications.
- Examination of tRFs' regulatory roles in post-transcriptional and translational processes.
Main Results:
- tRFs are generated from tRNA cleavage and exhibit diverse functions.
- Tumor cells exploit tRFs to facilitate metastatic development and survival.
- tRFs influence gene expression through microRNA-like activity and RNA-binding protein displacement.
- tRFs regulate translation initiation, ribosome synthesis, and epigenetic modifications.
Conclusions:
- tRFs are crucial mediators of cancer metastasis.
- Aberrant tRF expression contributes to the metastatic tumor microenvironment.
- tRFs represent promising biomarkers and therapeutic targets for combating cancer metastasis.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle

